Kimberly D Sloan-Stakleff - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kimberly D Sloan-Stakleff

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Clinical & Experimental Metastasis|November 24, 2004

Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combinationDouglas M Evans, Kimberly D Sloan Stakleff

The Breast Journal|May 12, 2001

Urokinase Plasminogen Activator Receptor (uPAR): A Potential Indicator of Invasion for In Situ Breast CancerDaniel P. Guyton, Douglas M. Evans, Kimberly D. Sloan-Stakleff

American Journal of Surgery|September 29, 2004

Does preoperative rofecoxib (Vioxx) decrease postoperative pain with laparoscopic cholecystectomy?Mark C Horattas, Steve Evans, Kimberly D Sloan-Stakleff, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Clinical & Experimental Metastasis|November 24, 2004

Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combinationDouglas M Evans, Kimberly D Sloan Stakleff

The Breast Journal|May 12, 2001

Urokinase Plasminogen Activator Receptor (uPAR): A Potential Indicator of Invasion for In Situ Breast CancerDaniel P. Guyton, Douglas M. Evans, Kimberly D. Sloan-Stakleff

American Journal of Surgery|September 29, 2004

Does preoperative rofecoxib (Vioxx) decrease postoperative pain with laparoscopic cholecystectomy?Mark C Horattas, Steve Evans, Kimberly D Sloan-Stakleff, et al.

Pageof 1